FDA’s 505(b)(2) Application

The 505(b)(2) new drug application (NDA) is an attractive regulatory and commercial strategy for clients. Learn the benefits, and similarities and dissimilarities with ANDA.

Introducing Upadhye Cwik LLP

Shashank Upadhye and Joseph (Joe) Cwik proudly announce the formation of the Upadhye Cwik LLP law firm along with the best team members they know.